Published in Arch Biochem Biophys on July 01, 1980
Footprinting DNA-protein complexes in situ following gel retardation assays using 1,10-phenanthroline-copper ion: Escherichia coli RNA polymerase-lac promoter complexes. Biochemistry (1987) 4.16
Presenilin-1 and -2 are molecular targets for gamma-secretase inhibitors. J Biol Chem (2000) 2.33
Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region. Proc Natl Acad Sci U S A (1989) 2.17
Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease. Mol Biochem Parasitol (1991) 1.95
Oxygen-dependent cleavage of DNA by the 1,10-phenanthroline . cuprous complex. Inhibition of Escherichia coli DNA polymerase I. J Biol Chem (1979) 1.91
Variable structures of Fis-DNA complexes determined by flanking DNA-protein contacts. J Mol Biol (1996) 1.74
Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat. Proc Natl Acad Sci U S A (1991) 1.69
Phenylketonuria in adulthood: a collaborative study. J Inherit Metab Dis (2002) 1.61
Nuclease activity of 1,10-phenanthroline-copper in study of protein-DNA interactions. Methods Enzymol (1991) 1.59
Nuclease activity of 1,10-phenanthroline-copper ion. Conformational analysis and footprinting of the lac operon. Biochemistry (1985) 1.54
Cleavage of deoxyribonucleic acid by the 1,10-phenanthroline-cuprous complex. Hydrogen peroxide requirement and primary and secondary structure specificity. Biochemistry (1981) 1.52
Nuclease activity of 1,10-phenanthroline-copper ion: reaction with CGCGAATTCGCG and its complexes with netropsin and EcoRI. Biochemistry (1986) 1.50
Nuclease activity of 1,10-phenanthroline-copper: sequence-specific targeting. Proc Natl Acad Sci U S A (1986) 1.43
Overexpression of human aspartyl(asparaginyl)beta-hydroxylase in hepatocellular carcinoma and cholangiocarcinoma. J Clin Invest (1996) 1.43
Chemical conversion of a DNA-binding protein into a site-specific nuclease. Science (1987) 1.37
Stethoscope acoustics. II. Transmission and filtration patterns. Circulation (1966) 1.35
Induction of kappa transcription by interferon-gamma without activation of NF-kappa B. Science (1988) 1.24
Transglutaminase inhibition by 2-[(2-oxopropyl)thio]imidazolium derivatives: mechanism of factor XIIIa inactivation. Biochemistry (1994) 1.22
cDNA cloning and expression of bovine aspartyl (asparaginyl) beta-hydroxylase. J Biol Chem (1992) 1.19
Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding. Proc Natl Acad Sci U S A (1988) 1.19
Holt-Oram syndrome: clinical and genetic study of a large family. Am J Hum Genet (1966) 1.18
Helix packing of lactose permease in Escherichia coli studied by site-directed chemical cleavage. Proc Natl Acad Sci U S A (1995) 1.15
Effects of N1-guanyl-1,7-diaminoheptane, an inhibitor of deoxyhypusine synthase, on the growth of tumorigenic cell lines in culture. Biochim Biophys Acta (1996) 1.15
Influence of a natural and a synthetic inhibitor of factor XIIIa on fibrin clot rheology. Biophys J (1999) 1.12
Conformational analysis of lac promoters using the nuclease activity of 1,10-phenanthroline-copper ion. Biopolymers (1985) 1.11
Skeletal manifestations of the Holt-Oram syndrome. Radiology (1970) 1.11
Ventricular pacing in children. Pacing Clin Electrophysiol (1982) 1.11
Protein-binding site at the immunoglobulin mu membrane polyadenylylation signal: possible role in transcription termination. Proc Natl Acad Sci U S A (1987) 1.10
Occurrence of beta-hydroxylated asparagine residues in non-vitamin K-dependent proteins containing epidermal growth factor-like domains. Proc Natl Acad Sci U S A (1987) 1.08
Responsible mothers and normal children: eugenics, nationalism, and welfare in post-revolutionary Mexico, 1920-1940. J Hist Sociol (1999) 1.08
Helicobacter pylori-selective antibacterials based on inhibition of pyrimidine biosynthesis. J Biol Chem (2000) 1.08
Chemical studies of enzyme active sites. Annu Rev Biochem (1975) 1.06
Secondary structure specificity of the nuclease activity of the 1,10-phenanthroline-copper complex. Proc Natl Acad Sci U S A (1984) 1.06
Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review. J Inherit Metab Dis (2004) 1.06
Early surgical correction of large ventricular septal defects. Pediatrics (1967) 1.05
Scission of RNA by the chemical nuclease of 1,10-phenanthroline-copper ion: preference for single-stranded loops. Nucleic Acids Res (1989) 1.04
Bovine liver aspartyl beta-hydroxylase. Purification and characterization. J Biol Chem (1991) 1.03
Chemical nuclease activity of 5-phenyl-1,10-phenanthroline-copper ion detects intermediates in transcription initiation by E. Coli RNA polymerase. Biochem Biophys Res Commun (1990) 1.02
Ligand binding properties of acetylcholinesterase determined with fluorescent probes. Biochemistry (1974) 1.02
Partial purification and characterization of bovine liver aspartyl beta-hydroxylase. J Biol Chem (1990) 1.00
Ventricular septal defect: results after repair in infancy. Am J Cardiol (1977) 0.99
Optimizing the targeted chemical nuclease activity of 1,10-phenanthroline-copper by ligand modification. Bioconjug Chem (1997) 0.99
Tricuspid atresia and the Wolff-Parkinson-White syndrome: evaluation methodology and successful surgical treatment of the combined disorders. Am Heart J (1981) 0.99
Transforming the Escherichia coli Trp repressor into a site-specific nuclease. Biochemistry (1993) 0.98
Products of DNA cleavage by the 1,10-phenanthroline-copper complex. Inhibitors of Escherichia coli DNA polymerase I. J Biol Chem (1982) 0.97
Inhibition of HIV-1 reverse transcriptase by pyridinone derivatives. Potency, binding characteristics, and effect of template sequence. J Biol Chem (1993) 0.94
Sequence-dependent variability of DNA structure. Influence of flanking sequences and fragment length on digestion by conformationally sensitive nucleases. J Biol Chem (1988) 0.93
Invertebrate aspartyl/asparaginyl beta-hydroxylase: potential modification of endogenous epidermal growth factor-like modules. Biochem Biophys Res Commun (1992) 0.93
A fully active catalytic domain of bovine aspartyl (asparaginyl) beta-hydroxylase expressed in Escherichia coli: characterization and evidence for the identification of an active-site region in vertebrate alpha-ketoglutarate-dependent dioxygenases. Proc Natl Acad Sci U S A (1994) 0.93
Liver fibrosis (cardiac cirrhosis) five years after modified Fontan operation for tricuspid atresia. J Thorac Cardiovasc Surg (1983) 0.93
Sequence-specific scission of DNA by the chemical nuclease activity of 1,10-phenanthroline-copper(I) targeted by RNA. Proc Natl Acad Sci U S A (1993) 0.92
Neurofibromatosis and congenital heart disease. Am J Roentgenol Radium Ther Nucl Med (1974) 0.92
Models for metalloenzymes. The zinc(II)-catalyzed transesterification of N-( -hydroxyethyl) ethylenediamine by p-nitrophenyl picolinate. J Am Chem Soc (1972) 0.91
Artificial nucleases. Chembiochem (2001) 0.91
Aspartyl beta-hydroxylase: in vitro hydroxylation of a synthetic peptide based on the structure of the first growth factor-like domain of human factor IX. Proc Natl Acad Sci U S A (1989) 0.91
DNA-binding proteins as site-specific nucleases. Mol Microbiol (1994) 0.90
Site-directed mutagenesis of residues in a conserved region of bovine aspartyl (asparaginyl) beta-hydroxylase: evidence that histidine 675 has a role in binding Fe2+. Biochemistry (1996) 0.90
The subcellular distribution of eukaryotic translation initiation factor, eIF-5A, in cultured cells. Exp Cell Res (1996) 0.90
Oto-palato-digital syndrome: comparison of clinical and radiographic manifestations in males and females. Am J Hum Genet (1972) 0.90
Oxidative chemical nucleases. Prog Nucleic Acid Res Mol Biol (1996) 0.89
A different approach for the total correction of tricuspid atresia. J Thorac Cardiovasc Surg (1976) 0.88
Interactions of substrates, inhibitors, and coenzymes at the active site of horse liver alcohol dehydrogenase. J Biol Chem (1967) 0.88
An approach to gene-specific transcription inhibition using oligonucleotides complementary to the template strand of the open complex. Proc Natl Acad Sci U S A (2000) 0.88
Sequence specificity of the deoxyribonuclease activity of 1,10-phenanthroline-copper ion. Biochemistry (1990) 0.88
Fluorescent probes of acetylcholinesterase. Biochemistry (1972) 0.87
Inhibition of human immunodeficiency virus type 1 integrase by a hydrophobic cation: the phenanthroline-cuprous complex. AIDS Res Hum Retroviruses (1995) 0.87
1,10-Phenanthroline-cuprous ion complex, a potent inhibitor of DNA and RNA polymerases. Biochem Biophys Res Commun (1978) 0.87
Hybridization of a complementary ribooligonucleotide to the transcription start site of the lacUV-5-Escherichia coli RNA polymerase open complex. Potential for gene-specific inactivation reagents. Biochemistry (1994) 0.87
The hand-food-uterus syndrome: a new hereditary disorder characterized by hand and foot dysplasia, dermatoglyphic abnormalities, and partial duplication of the female genital tract. J Pediatr (1970) 0.87
R-loop stability as a function of RNA structure and size. Nucleic Acids Res (1995) 0.86
Identification of new Fis binding sites by DNA scission with Fis-1,10-phenanthroline-copper(I) chimeras. Biochemistry (1996) 0.86
Model dehydrogenase reactions. Reduction of N-methylacridinium ion by reduced nicotinamide adenine dinucleotide and its derivatives. J Am Chem Soc (1973) 0.86
Terminal labeling of high molecular weight ribonucleic acid with dimedone. Biochemistry (1970) 0.85
Footprinting RNA-protein complexes following gel retardation assays: application to the R-17-procoat-RNA and tat--TAR interactions. Nucleic Acids Res (1994) 0.85
Inhibition of E. coli DNA polymerase I by 1,10-phenanthroline. Biochem Biophys Res Commun (1977) 0.85
A new family with the hand-foot-genital syndrome--a wider spectrum of the hamd-foot-uterus syndrome. Birth Defects Orig Artic Ser (1975) 0.84
The synthesis of enzyme-bound ATP by soluble chloroplast coupling factor 1. J Biol Chem (1982) 0.84
Protease activity of 1,10-phenanthroline-copper(I). Targeted scission of the catalytic site of carbonic anhydrase. Biochemistry (1998) 0.84
The synthesis of ATP by the membrane-bound ATP synthase complex from medium 32Pi under completely uncoupled conditions. J Biol Chem (1983) 0.83
Development of a carbon dioxide-capture assay in microtiter plate for aspartyl-beta-hydroxylase. Anal Biochem (1999) 0.83
Skeletal anomalies in genetically determined congenital heart disease. Radiol Clin North Am (1971) 0.83
Selective inhibition of bacterial dihydroorotate dehydrogenases by thiadiazolidinediones. Biochem Pharmacol (2000) 0.82
Pulmonary lymphangiectasis in Noonan syndrome. AJR Am J Roentgenol (1980) 0.82
Atrial overdrive pacing for conversion of atrial flutter in children. Pediatrics (1985) 0.82
Oligoribonucleotide-based gene-specific transcription inhibitors that target the open complex. Methods (2001) 0.81
Nuclease activity of 1,10-phenanthroline-copper. New conjugates with low molecular weight targeting ligands. Bioconjug Chem (1993) 0.81
Allosteric effects of volatile anesthetics on the membrane-bound acetylcholine receptor protein. I. Stabilization of the high-affinity state. Mol Pharmacol (1981) 0.81
1,10-Phenanthroline-copper, a footprinting reagent for single-stranded regions of RNAs. Biochem Biophys Res Commun (1992) 0.80
DL-threo-beta-fluoroasparagine inhibits asparagine-linked glycosylation in cell-free lysates. J Biol Chem (1983) 0.80
The site of auramine O binding to horse liver alcohol dehydrogenase. J Biol Chem (1972) 0.80
Scission of DNA at a preselected sequence using a single-strand-specific chemical nuclease. Chem Biol (1998) 0.80
Oligonucleotide-directed nucleic acid scission by micrococcal nuclease. Biochemistry (1994) 0.79